Quarterly report · Q3
4820.TEDINET S100S823
Period2023-01-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥15.2bn | 2023-01-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥16.9bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.5bn | 2022-01-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥1.8bn | 2023-01-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥2.1bn | 2022-01-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥2.2bn | 2023-01-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.8bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.5bn | 2022-01-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.1bn | 2023-01-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.5bn | 2022-01-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.4bn | 2023-01-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.9bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.6bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.4bn | 2023-01-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥1.6bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥29.6bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥26.3bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥25.0bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥9.7bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥6.8bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥19.9bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥19.5bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥19.2bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.2bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.9bn | at 2022-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥19.21 | 2023-01-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.04 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.75 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.21 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.85 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥19.15 | 2023-01-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.66 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥23.13 | 2022-01-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 67.0% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.7% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.3% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 42
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2023-01-01 → 2023-09-30 | ¥671m |
| Otherother segments | revenue external | 2023-01-01 → 2023-09-30 | ¥593m |
| Otherother segments | revenue intersegment | 2023-01-01 → 2023-09-30 | ¥77m |
| Otherother segments | segment profit | 2023-01-01 → 2023-09-30 | ¥25m |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-09-30 | −¥92m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-09-30 | −¥92m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-09-30 | ¥34m |
| jpcrp040300-q3r_E05155-000Care Welfare IT Systems Businessreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥416m |
| jpcrp040300-q3r_E05155-000Care Welfare IT Systems Businessreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥416m |
| jpcrp040300-q3r_E05155-000Care Welfare IT Systems Businessreportable segment | segment profit | 2023-01-01 → 2023-09-30 | −¥404m |
| jpcrp040300-q3r_E05155-000Medicine Receipt Computer And Related Businessreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥2.2bn |
| jpcrp040300-q3r_E05155-000Medicine Receipt Computer And Related Businessreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥2.2bn |
| jpcrp040300-q3r_E05155-000Medicine Receipt Computer And Related Businessreportable segment | segment profit | 2023-01-01 → 2023-09-30 | −¥20m |
| jpcrp040300-q3r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥12.0bn |
| jpcrp040300-q3r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥11.9bn |
| jpcrp040300-q3r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-09-30 | ¥14m |
| jpcrp040300-q3r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥2.2bn |
| —segment total | revenue | 2023-01-01 → 2023-09-30 | ¥15.3bn |
| —segment total | revenue external | 2023-01-01 → 2023-09-30 | ¥15.2bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-09-30 | ¥92m |
| —segment total | segment profit | 2023-01-01 → 2023-09-30 | ¥1.8bn |
| Otherother segments | revenue | 2022-01-01 → 2022-09-30 | ¥528m |
| Otherother segments | revenue external | 2022-01-01 → 2022-09-30 | ¥501m |
| Otherother segments | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥27m |
| Otherother segments | segment profit | 2022-01-01 → 2022-09-30 | −¥35m |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-09-30 | −¥37m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-09-30 | −¥37m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-09-30 | ¥22m |
| jpcrp040300-q3r_E05155-000Care Welfare IT Systems Businessreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥401m |
| jpcrp040300-q3r_E05155-000Care Welfare IT Systems Businessreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥401m |
| jpcrp040300-q3r_E05155-000Care Welfare IT Systems Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥33m |
| jpcrp040300-q3r_E05155-000Medicine Receipt Computer And Related Businessreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥1.6bn |
| jpcrp040300-q3r_E05155-000Medicine Receipt Computer And Related Businessreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥1.6bn |
| jpcrp040300-q3r_E05155-000Medicine Receipt Computer And Related Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥210m |
| jpcrp040300-q3r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥10.0bn |
| jpcrp040300-q3r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥10.0bn |
| jpcrp040300-q3r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥10m |
| jpcrp040300-q3r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥2.4bn |
| —segment total | revenue | 2022-01-01 → 2022-09-30 | ¥12.5bn |
| —segment total | revenue external | 2022-01-01 → 2022-09-30 | ¥12.5bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥37m |
| —segment total | segment profit | 2022-01-01 → 2022-09-30 | ¥2.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 382
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember | 9975000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember | 1623000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember | 401000000 | JPY |
| Net sales | Prior1YTDDuration_OtherReportableSegmentsMember | 528000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 12529000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -37000000 | JPY |
| Net sales | Prior1YTDDuration | 12491000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember | 2370000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember | -210000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember | -33000000 | JPY |
| Operating income | Prior1YTDDuration_OtherReportableSegmentsMember | -35000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 2091000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | 22000000 | JPY |
| Operating income | Prior1YTDDuration | 2113000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember | 11939000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember | 2249000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember | 416000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OtherReportableSegmentsMember | 593000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 15198000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | CurrentYTDDuration | 15198000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember | 14000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_OtherReportableSegmentsMember | 77000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 92000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -92000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | - | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember | 11953000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember | 2249000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember | 416000000 | JPY |
| Net sales | CurrentYTDDuration_OtherReportableSegmentsMember | 671000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 15290000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -92000000 | JPY |
| Net sales | CurrentYTDDuration | 15198000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember | 2169000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember | -20000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember | -404000000 | JPY |
| Operating income | CurrentYTDDuration_OtherReportableSegmentsMember | 25000000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 1769000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | 34000000 | JPY |
| Operating income | CurrentYTDDuration | 1804000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の4の7第1項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)近畿財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-11-10 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第41期第3四半期(自 2023年7月1日 至 2023年9月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社イーエムシステムズ(商号 株式会社EMシステムズ) | |
| Company name in english cover page | FilingDateInstant | EM SYSTEMS CO.,LTD. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長執行役員 國光 宏昌 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |